ABPI ACCENTIA BIOPHARMACE

Accentia Biopharmaceuticals, Inc. (Accentia Biopharmaceuticals) is a biopharmaceutical company focused on the development and commercialization of late-stage clinical products in the therapeutic areas of respiratory disease and oncology. The Company operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products with an emphasis on the respiratory and oncology therapeutic areas. The products that are being developed in this segment consist of SinuNase and Biovaxid. In the Specialty Pharmaceuticals segment, Accentia Biopharmaceuticals sells a portfolio of 10 pharmaceutical products that includes Xodol, Respi~TANN, a line of HISTEX products and two products that are co-promoted by the Company. The Specialty Pharmaceuticals segment also has a pipeline of additional products under development through Accentia Biopharmaceuticals' development partners.